{
    "2019-03-01": [
        [
            {
                "time": "2019-03-01",
                "original_text": "云南白药复牌现半年股价新高点，市值逾900亿",
                "features": {
                    "keywords": [
                        "云南白药",
                        "复牌",
                        "股价新高",
                        "市值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "医疗保健：国内恶性肿瘤发病数据梳理 荐5股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "恶性肿瘤",
                        "发病数据"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "信息速递 | 2019年3月1日格林大华信息速递",
                "features": {
                    "keywords": [
                        "信息速递",
                        "格林大华"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "MSCI概念指数走强，康美药业涨近7%",
                "features": {
                    "keywords": [
                        "MSCI",
                        "概念指数",
                        "康美药业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "云南白药高开逾4%，逾500亿元整体上市方案获通过",
                "features": {
                    "keywords": [
                        "云南白药",
                        "高开",
                        "整体上市",
                        "方案通过"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "云南白药510亿吸收合并白药控股过会 A股并购大提速",
                "features": {
                    "keywords": [
                        "云南白药",
                        "吸收合并",
                        "白药控股",
                        "A股并购"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "1日早新闻丨重磅！MSCI宣布将上调A股权重至20%",
                "features": {
                    "keywords": [
                        "MSCI",
                        "A股权重",
                        "上调"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "云南白药重组获有条件通过 必要性与合法性引关注",
                "features": {
                    "keywords": [
                        "云南白药",
                        "重组",
                        "有条件通过",
                        "必要性",
                        "合法性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "云南白药超500亿整体上市方案获证监会审核通过 3月1日复牌",
                "features": {
                    "keywords": [
                        "云南白药",
                        "整体上市",
                        "方案通过",
                        "证监会",
                        "复牌"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}